GENERIC NAME OF THE MEDICINAL PRODUCT:
b) Leuprolide Acetate Injection 1mg/0.5ml
c) Leuprolide Acetate Injection 14mg/2.8ml (1mg/0.2ml)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each ml contains
Leuprolide Acetate USP………….1mg
Benzyl Alcohol NF…………………….9mg
(as preservative)
Sodium Chloride USP…………..6.3mg
Water for Injection USP….…..q.s.
b) Leuprolide Acetate Injection 1mg/0.5ml
Each 0.5 ml contains
Leuprolide Acetate USP………….1mg
Benzyl Alcohol NF…………………….4.5mg
(as preservative)
Sodium Chloride USP…………..3.15mg
Water for Injection USP….…..q.s.
c) Leuprolide Acetate Injection 14mg/2.8ml (1mg/0.2ml)
Each 0.2 ml contains
Leuprolide Acetate USP………….1mg
Benzyl Alcohol NF…………………….1.8mg
(as preservative)
Sodium Chloride USP…………..0.95mg
Water for Injection USP….…..q.s.
THERAPEUTIC INDICATION:
PACKING:
2) 1mg/0.5ml
3) 14mg/2.8ml (1mg/0.2ml) – 14 Day Patient Administration Kit
Contents: one 2.8ml Vial Leuprolide Acetate, 14 Disposable syringes, 28 Alcohol Swabs, Prescribing Information
DIRECTION OF USE:
See package insert for complete prescribing information.
CAUTION & WARNING:
WARNING: Cytotoxic Agent - To be sold by retail on the prescription of an Oncologist/ Cancer Hospital/ Institution.
Important (14mg/2.8ml (1mg/0.2ml)): Dispense with prescription label positioned to remain with kit during use.
Fragile. Handle with care.
Not for use in newborns.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
Discard any unused solution.
Keep out of reach of children.
STORAGE & DOSAGE:
Dosage: As directed by the Oncologist.
Leuprolide Acetate Injection 1mg/0.5ml Technical Specification:
| Product Name: | Leuprolide Acetate Injection 1mg/0.5ml |
| Brand Name: | Leuprolide Acetate |
| Strength: | 1mg/ml (4mg/4ml), 1mg/0.5ml, 14mg/2.8ml (1mg/0.2ml) |
| Dosage Form: | Liquid Injection |
| Packing: | 1mg/0.5ml – SINGLE USE AMPOULE 1mg/ml (4mg/4ml), 14mg/2.8ml (1mg/0.2ml) – MULTIPLE USE VIAL |
| Route of Administration: | For subcutaneous use only |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Anti-Cancer |
| Indication: | Leuprorelin also known as leuprolide is a manufactured version of a hormone used to treat prostate cancer. It is also being studied in the treatment of other conditions and types of cancer. |
| Storage: | Store between 2°C to 8°C. Protect from light. Do not freeze. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Leuprolide Acetate Injection 1mg/0.5ml
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Leuprolide Acetate Injection 1mg/0.5ml
Each 0.5 ml contains
Leuprolide Acetate USP………….1mg
Benzyl Alcohol NF…………………….4.5mg
(as preservative)
Sodium Chloride USP…………..3.15mg
Water for Injection USP….…..q.s.
THERAPEUTIC INDICATION:
Leuprorelin also known as leuprolide is a manufactured version of a hormone used to treat prostate cancer. It is also being studied in the treatment of other conditions and types of cancer.
PACKING:
- 1mg/ml (4mg/4ml)
- 1mg/0.5ml
- 14mg/2.8ml (1mg/0.2ml) – 14 Day Patient Administration Kit
Contents: one 2.8ml Vial Leuprolide Acetate, 14 Disposable syringes, 28 Alcohol Swabs, Prescribing Information
DIRECTION OF USE:
For subcutaneous use only
See package insert for complete prescribing information.
CAUTION & WARNING:
CAUTION: This injection should not be used if it contains visible particulate matter.
WARNING: Cytotoxic Agent – To be sold by retail on the prescription of an Oncologist/ Cancer Hospital/ Institution.
Important (14mg/2.8ml (1mg/0.2ml)): Dispense with prescription label positioned to remain with kit during use.
Fragile. Handle with care.
Not for use in newborns.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
Discard any unused solution.
Keep out of reach of children.
STORAGE & DOSAGE:
Storage: Store between 2°C to 8°C. Protect from light. Do not freeze.
Dosage: As directed by the Oncologist.


















